Key Metrics
2.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Immunology
SJR
- Q3 Immunology
- Q3 Immunology and Allergy
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.58
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
4%
4 to 6 months
49%
7 to 9 months
32%
Above 9 months
14%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Inflammation
- Renal function
- Eosinophilic
- Acute pancreatitis
- Bioinformatics analysis
- Immunoglobulin G
- Lupus nephritis
- Heart failure
- Chronic hepatitis
- Prognostic biomarker
- Lung
- Food allergy
- Antigen
- Severe asthma
- Lipopolysaccharide
- Emergency department
- Observational study
- Omalizumab
- Systematic review
- Bone marrow
Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Article-by-article |
| Article Processing Charges | EUR 2550 | GBP 2100 | USD 3267 |
| Publication Time | 8 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Article-by-article |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 8 |
| Article Processing Charges | EUR 2550 | GBP 2100 | USD 3267 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Immunity, inflammation and disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Blocking of Tim-3 Ameliorates Spinal Cord Ischemia-Reperfusion Injury Through Inhibiting Neuroinflammation and Promoting M1-to-M2 Phenotypic Polarization of Microglia.
- 1 Dec 24
- Immunity, inflammation and disease
-
Full paper
Issue Information
- 1 Dec 24
- Immunity, Inflammation and Disease
-
Full paper
The Diagnosis and Prognosis Value of Circulating Exosomal lncRNA MALAT1 and LNC_000226 in Patients With Acute Myocardial Infarction: An Observational Study.
- 1 Dec 24
- Immunity, inflammation and disease
-
Full paper
Association of the Inflammatory Burden Index With Increased Mortality Among Cancer Patients: Insights From the NHANES Study.
- 1 Dec 24
- Immunity, inflammation and disease
-
Full paper
Serotype 3 Streptococcus pneumoniae Escapes the Immune Responses Induced by PCV13 in Mice With High Susceptibility to Infection.
- 1 Dec 24
- Immunity, inflammation and disease
-
Full paper
Inflammatory, Hematological, and Biochemical Biomarkers in COVID-19 Patients.
- 1 Dec 24
- Immunity, inflammation and disease
Scite analysis
Powered by scite_
1.4k articles received 8.1k citations see all
- 429 Supporting
- 7,516 Mentioning
- 45 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 4 Corrections
- 4 Errata
- 0 Expression of Concern
FAQs
How long has Immunity, inflammation and disease been actively publishing?
Immunity, inflammation and disease has been in operation since 2013 till date.
What is the publishing frequency of Immunity, inflammation and disease ?
Immunity, inflammation and disease published with a Article-by-article frequency.
How many articles did Immunity, inflammation and disease publish last years ?
In 2023, Immunity, inflammation and disease published 363 articles.
What is the eISSN & pISSN for Immunity, inflammation and disease ?
For Immunity, inflammation and disease,eISSN is 2050-4527 and pISSN is2050-4527.
What is Citescore for Immunity, inflammation and disease ?
Citescore for Immunity, inflammation and disease is 2.6.
What is SNIP score for Immunity, inflammation and disease ?
SNIP score for Immunity, inflammation and disease is 0.58.
What is the SJR for Immunity, inflammation and disease ?
SJR for Immunity, inflammation and disease is Q3.
Who is the publisher of Immunity, inflammation and disease ?
WILEY is the publisher of Immunity, inflammation and disease.